HealthEquity Statistics
Total Valuation
HealthEquity has a market cap or net worth of $9.41 billion. The enterprise value is $10.22 billion.
| Market Cap | 9.41B |
| Enterprise Value | 10.22B |
Important Dates
The next confirmed earnings date is Tuesday, March 18, 2025, after market close.
| Earnings Date | Mar 18, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
HealthEquity has 86.66 million shares outstanding. The number of shares has increased by 2.60% in one year.
| Current Share Class | 86.66M |
| Shares Outstanding | 86.66M |
| Shares Change (YoY) | +2.60% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 1.65% |
| Owned by Institutions (%) | 104.00% |
| Float | 85.20M |
Valuation Ratios
The trailing PE ratio is 99.81 and the forward PE ratio is 31.17. HealthEquity's PEG ratio is 1.26.
| PE Ratio | 99.81 |
| Forward PE | 31.17 |
| PS Ratio | 8.18 |
| Forward PS | 7.32 |
| PB Ratio | 4.44 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 27.77 |
| P/OCF Ratio | 27.59 |
| PEG Ratio | 1.26 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 28.33, with an EV/FCF ratio of 30.17.
| EV / Earnings | 105.73 |
| EV / Sales | 8.89 |
| EV / EBITDA | 28.33 |
| EV / EBIT | 51.20 |
| EV / FCF | 30.17 |
Financial Position
The company has a current ratio of 3.20, with a Debt / Equity ratio of 0.53.
| Current Ratio | 3.20 |
| Quick Ratio | 2.78 |
| Debt / Equity | 0.53 |
| Debt / EBITDA | 3.10 |
| Debt / FCF | 3.35 |
| Interest Coverage | 3.38 |
Financial Efficiency
Return on equity (ROE) is 4.70% and return on invested capital (ROIC) is 4.04%.
| Return on Equity (ROE) | 4.70% |
| Return on Assets (ROA) | 3.79% |
| Return on Invested Capital (ROIC) | 4.04% |
| Return on Capital Employed (ROCE) | 5.99% |
| Revenue Per Employee | $365,189 |
| Profits Per Employee | $30,699 |
| Employee Count | 3,150 |
| Asset Turnover | 0.35 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, HealthEquity has paid $19.09 million in taxes.
| Income Tax | 19.09M |
| Effective Tax Rate | 16.49% |
Stock Price Statistics
The stock price has increased by +33.53% in the last 52 weeks. The beta is 0.55, so HealthEquity's price volatility has been lower than the market average.
| Beta (5Y) | 0.55 |
| 52-Week Price Change | +33.53% |
| 50-Day Moving Average | 103.22 |
| 200-Day Moving Average | 88.13 |
| Relative Strength Index (RSI) | 49.08 |
| Average Volume (20 Days) | 703,302 |
Short Selling Information
The latest short interest is 4.40 million, so 5.07% of the outstanding shares have been sold short.
| Short Interest | 4.40M |
| Short Previous Month | 4.52M |
| Short % of Shares Out | 5.07% |
| Short % of Float | 5.16% |
| Short Ratio (days to cover) | 6.05 |
Income Statement
In the last 12 months, HealthEquity had revenue of $1.15 billion and earned $96.70 million in profits. Earnings per share was $1.09.
| Revenue | 1.15B |
| Gross Profit | 751.54M |
| Operating Income | 199.71M |
| Pretax Income | 98.27M |
| Net Income | 96.70M |
| EBITDA | 360.89M |
| EBIT | 199.71M |
| Earnings Per Share (EPS) | $1.09 |
Balance Sheet
The company has $322.16 million in cash and $1.14 billion in debt, giving a net cash position of -$813.03 million or -$9.38 per share.
| Cash & Cash Equivalents | 322.16M |
| Total Debt | 1.14B |
| Net Cash | -813.03M |
| Net Cash Per Share | -$9.38 |
| Equity (Book Value) | 2.12B |
| Book Value Per Share | 24.47 |
| Working Capital | 340.71M |
Cash Flow
In the last 12 months, operating cash flow was $341.18 million and capital expenditures -$2.32 million, giving a free cash flow of $338.87 million.
| Operating Cash Flow | 341.18M |
| Capital Expenditures | -2.32M |
| Free Cash Flow | 338.87M |
| FCF Per Share | $3.91 |
Margins
Gross margin is 65.33%, with operating and profit margins of 17.36% and 8.41%.
| Gross Margin | 65.33% |
| Operating Margin | 17.36% |
| Pretax Margin | 10.07% |
| Profit Margin | 8.41% |
| EBITDA Margin | 31.37% |
| EBIT Margin | 17.36% |
| FCF Margin | 29.46% |
Dividends & Yields
HealthEquity does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.60% |
| Shareholder Yield | -2.60% |
| Earnings Yield | 1.03% |
| FCF Yield | 3.60% |
Analyst Forecast
The average price target for HealthEquity is $111.23, which is 2.42% higher than the current price. The consensus rating is "Buy".
| Price Target | $111.23 |
| Price Target Difference | 2.42% |
| Analyst Consensus | Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (5Y) | 14.91% |
| EPS Growth Forecast (5Y) | 71.25% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HealthEquity has an Altman Z-Score of 3.67 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.67 |
| Piotroski F-Score | 6 |